 giant cell versu lymphocyt myocard comparison clinic featur long-term outcom background giant cell myocard premortem littl natur histori addit compar studi lymphocyt myocard method result clinic featur serial chang left ventricular fraction lvef outcom patient myocard patient giant cell myocard group lymphocyt myocard group age present gender distribut durat symptom initi lvef hemodynam group ventricular tachycardia group patient group atrioventricular block insert common group group left ventricular systol function follow-up group patient lvef group patient lvef net chang initi final lvef signific differ evid giant cell group lymphocyt group proport patient group transplant versu actuari surviv year differ giant cell group lymphocyt group conclus giant cell myocard preval ventricular tachycardia pacemak requir likelihood advers event cardiovascular mortal cardiac transplant patient giant cell myocard lymphocyt myocard progress declin left ventricular systol function giant cell myocard